PDL BioPharma (PDLI) News Today → Biden out June 13; Kamala won’t replace him? (From Paradigm Press) (Ad) Free PDLI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGT Biopharma Inc GTBPmorningstar.com - February 23 at 6:12 PMHealth Winners & Losers: Maxygenthestreet.com - October 24 at 10:27 AMPDLI Historical Datainvesting.com - October 18 at 4:54 PMABVC - ABVC BioPharma, Inc.finance.yahoo.com - June 28 at 6:50 PMRDHL - RedHill Biopharma Ltd.finance.yahoo.com - June 23 at 2:16 PMLABPseekingalpha.com - March 12 at 9:26 PMA Persons Deprived of Liberty (PDL) interacts with his pet mouse inside the jailmsn.com - January 15 at 6:52 PMPDL BioPharma Stock To Go Ex-dividend Monday (PDLI)thestreet.com - January 4 at 11:32 PMPDL BioPharma Stock To Go Ex-dividend Tomorrow (PDLI)thestreet.com - December 14 at 3:41 PMCramer's 'Mad Money' Recap: Politics Is Overratedthestreet.com - August 6 at 9:40 PMSteris (STE)forbes.com - May 21 at 11:08 PM Get PDL BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for PDLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden out June 13; Kamala won’t replace him? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election. See who it is HERE. PDLI Media Mentions By Week PDLI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PDLI News Sentiment▼0.000.33▲Average Medical News Sentiment PDLI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PDLI Articles This Week▼00▲PDLI Articles Average Week Get PDL BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for PDLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VectivBio News Aclarion News Alpha Tau Medical News American Oncology Network News Artelo Biosciences News bioAffinity Technologies News BriaCell Therapeutics News Bullfrog AI News CareCloud News CareCloud News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PDLI) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsYour bank is lying to you.MyBankTrackerTrump just won 2024Porter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingA once-in-a-century investment opportunityStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PDL BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
